Literature DB >> 32185674

Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism.

Caio Mateus Silva1, Gustavo Duarte Ferrari2, Luciane Carla Alberici3, Osmar Malaspina4, Karen C M Moraes5.   

Abstract

Fibrosis process in the liver is a clinical condition established in response to chronic lesions and may be reversible in many situations. In this process, hepatic stellate cells (HSCs) activate and produce extracellular matrix compounds. During fibrosis, the lipid metabolism is also altered and contributes to the transdifferentiation of the HSCs. Thus, controlling lipid metabolism in HSCs is suggested as a method to control or reverse the fibrotic condition. In the search for therapies that modulate lipid metabolism and treat liver diseases, silymarin has been identified as a relevant natural compound to treat liver pathologies. The present study aimed to evaluate the cellular and molecular effects of silymarin in the transdifferentiation process of HSCs (LX-2) from activated phenotype to a more quiesced-like cells , also focusing on understanding the modulatory effects of silymarin on lipid metabolism of HSCs. In our analyses, 100 µM of silymarin reduced the synthesis of actin filaments in activated cells, the synthesis of the protein level of α-SMA, and other pro-fibrotic factors such as CTGF and PFGF. The concentration of 150 µM silymarin did not reverse the activation aspects of LX-2 cells. However, both evaluated concentrations of the natural compound protected the cells from the negative effects of dimethyl sulfoxide (DMSO). Furthermore, we evaluated lipid-related molecules correlated to the transdifferentiation process of LX-2, and 100 µM of silymarin demonstrated to control molecules associated with lipid metabolism such as FASN, MLYCD, ACSL4, CPTs, among others. In contrast, cellular incubation with 150 µM of silymarin increased the synthesis of long-chain fatty acids and triglycerides, regarding the higher presence of DMSO (v/v) in the solvent. In conclusion, silymarin acts as a hepatoprotective agent and modulates the pro-fibrogenic stimuli of LX-2 cells, whose effects depend on stress levels in the cellular environment.

Entities:  

Keywords:  Hepatic stellate cell; Lipid metabolism; Liver fibrosis; Natural compound

Mesh:

Substances:

Year:  2020        PMID: 32185674     DOI: 10.1007/s11010-020-03717-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  95 in total

1.  Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction.

Authors:  Young Mi Song; Sun-Ok Song; Yong-Keun Jung; Eun-Seok Kang; Bong Soo Cha; Hyun Chul Lee; Byung-Wan Lee
Journal:  Autophagy       Date:  2012-06-22       Impact factor: 16.016

2.  Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration.

Authors:  Alexander Kikuchi; Tirthadipa Pradhan-Sundd; Sucha Singh; Shanmugam Nagarajan; Nick Loizos; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

3.  The effect of vitamin A on CCl4-induced hepatic injuries in rats: a histochemical, immunohistochemical and ultrastructural study.

Authors:  Semiha Noyan; Ilkin Cavusoglu; F Zehra Minbay
Journal:  Acta Histochem       Date:  2005-10-26       Impact factor: 2.479

Review 4.  Roles of the lipid metabolism in hepatic stellate cells activation △.

Authors:  Xin-yan Jing; Xue-feng Yang; Kai Qing; Yan Ou-yang
Journal:  Chin Med Sci J       Date:  2013-12

Review 5.  Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects.

Authors:  Nuno C Santos; J Figueira-Coelho; J Martins-Silva; Carlota Saldanha
Journal:  Biochem Pharmacol       Date:  2003-04-01       Impact factor: 5.858

6.  Protection against post-ischemic mitochondrial injury in rat liver by silymarin or TUDC.

Authors:  Anabela P. Rolo; Paulo J. Oliveira; António J.M. Moreno; Carlos M. Palmeira
Journal:  Hepatol Res       Date:  2003-07       Impact factor: 4.288

7.  Chebulic acid prevents hepatic fibrosis induced by advanced glycation end-products in LX-2 cell by modulating Nrf2 translocation via ERK pathway.

Authors:  Yun-Chang Koo; Min Cheol Pyo; Mi-Hyun Nam; Chung-Oui Hong; Sung-Yong Yang; Kwang-Won Lee
Journal:  Toxicol In Vitro       Date:  2016-03-25       Impact factor: 3.500

8.  Dimethyl Sulfoxide Decreases Levels of Oxylipin Diols in Mouse Liver.

Authors:  Poonamjot Deol; Jun Yang; Christophe Morisseau; Bruce D Hammock; Frances M Sladek
Journal:  Front Pharmacol       Date:  2019-05-29       Impact factor: 5.810

9.  Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.

Authors:  Christine C Hsu; Juliane S Troeger; Ingmar Mederacke; Peter Huebener; Xueru Mu; Dianne H Dapito; Jean-Philippe Pradere; Robert F Schwabe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation.

Authors:  Chin Fung Kelvin Kan; Amar Bahadur Singh; Diana M Stafforini; Salman Azhar; Jingwen Liu
Journal:  J Lipid Res       Date:  2014-05-30       Impact factor: 5.922

View more
  3 in total

1.  The functional activity of the miR-1914-5p in lipid metabolism of the hepatocarcinoma cell line HepG2: a potential molecular tool for controlling hepatic cellular migration.

Authors:  Marina Bonfogo da Silveira; Camila Cristiane Pansa; Osmar Malaspina; Karen C M Moraes
Journal:  Mol Biol Rep       Date:  2021-04-28       Impact factor: 2.316

2.  Proteomic Changes of Activated Hepatic Stellate Cells.

Authors:  Maximilian Schinagl; Tamara Tomin; Juergen Gindlhuber; Sophie Honeder; Raphael Pfleger; Matthias Schittmayer; Michael Trauner; Ruth Birner-Gruenberger
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 6.208

3.  The Stiffness of Cardiac Fibroblast Substrates Exerts a Regulatory Influence on Collagen Metabolism via α2β1 Integrin, FAK and Src Kinases.

Authors:  Małgorzata Gałdyszyńska; Paulina Radwańska; Jacek Szymański; Jacek Drobnik
Journal:  Cells       Date:  2021-12-11       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.